Assistant Professor of Practice in Biology
Affiliation: NYU Abu Dhabi
Education: PhD in biophysics from Stockholm University
Research Areas: delivery of antitumor agents and therapeutics for amyloid diseases
Mazin Magzoub is a biophysicist specializing in the development of novel methods for the delivery of antitumor agents and therapeutics for amyloid diseases (e.g. Alzheimer’s and prion diseases). Prior to joining NYUAD, Dr. Magzoub was a postdoctoral scholar at the University of California, San Francisco, where he developed novel biophysical methods for measurement of macromolecule diffusion deep in tissues such as tumors and brain. Subsequently, as an Associate Research Scientist in Andrew Miranker’s laboratory at Yale University, he worked on elucidating the molecular mechanisms underlying type 2 diabetes.
Dr. Magzoub received his PhD in biophysics from Stockholm University in 2004, where he studied the biophysical properties of cell-penetrating peptides, a class of peptides with the ability to mediate the cellular import of therapeutic compounds with high efficiency and low toxicity.